Status:
COMPLETED
Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Roche Pharma AG
Conditions:
Transplantation
Infection
Eligibility:
All Genders
18+ years
Brief Summary
This study will investigate the clinical variables that may be used to predict who among the solid organ transplant recipients will develop cytomegalovirus (CMV) disease after completing antiviral pro...
Detailed Description
This study will investigate the clinical and laboratory variables that may be used to predict who among the solid organ transplant recipients will develop CMV disease after completing antiviral prophy...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Recipients of liver, kidney, pancreas, heart or lung transplantation
Exclusion
Key Trial Info
Start Date :
November 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00170170
Start Date
November 1 2004
End Date
June 1 2007
Last Update
February 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905